Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator
- PMID: 3129817
- DOI: 10.1016/0049-3848(88)90218-6
Activation of Val442-plasminogen (mini-plasminogen) by urokinase, streptokinase and tissue plasminogen activator
Abstract
Glu-plasminogen (Glu-plg), Lys-plg and Val442-plg (mini-plg) were activated by urokinase (UK), streptokinase (SK) or tissue plasminogen activator (t-PA). Their activation rates were kinetically analyzed. UK activated Lys-plg with smaller Km and nearly identical Vmax as Glu-plg. Mini-plg was activated by UK with higher Vmax but with the same Km as Glu-plg. On the other hand, t-PA activated Glu-plg, Lys-plg and mini-plg with the same Vmax, but Km was in the order of Glu-plg greater than mini-plg greater than Lys-plg. Fibrin hardly enhanced the UK activation of mini-plg, and fibrinogen, fragment D or E did not enhance the activation of mini-plg by UK. Only D domain, but not E domain, complexed with K5 of mini-plg and SK hydrolysed S-2251 faster than a dimolecular complex of mini-plg and SK, thus a trimolecular mixture of D, SK and mini-plg having a better activator activity than SK-mini-plg complex. In the t-PA activation of mini-plg, fibrin and fibrinogen enhanced the activation, but fragment D or E was ineffective, suggesting that a molecule containing more than one domain was required for the enhanced activation of mini-plg by t-PA.
Similar articles
-
The activation of Glu- and Lys-plasminogens by streptokinase: effects of fibrin, fibrinogen and their degradation products.Thromb Res. 1985 Feb 1;37(3):465-75. doi: 10.1016/0049-3848(85)90075-1. Thromb Res. 1985. PMID: 3992529
-
Kinetic analyses of potentiation of plasminogen activation by streptokinase in the presence of fibrin or its degradation products.Haemostasis. 1987;17(1-2):1-7. doi: 10.1159/000215552. Haemostasis. 1987. PMID: 3596355
-
Enhanced activator activity of the mixture of streptokinase and a modified form of plasminogen (Lys-plasminogen) in the presence of fibrin: role of conformational change of plasminogen.Haemostasis. 1988;18(2):106-12. doi: 10.1159/000215790. Haemostasis. 1988. PMID: 3410360
-
Physiology of plasminogen: with special reference to activation and degradation.Haemostasis. 1988;18 Suppl 1:25-35. doi: 10.1159/000215834. Haemostasis. 1988. PMID: 3280423 Review.
-
Review of studies with plasminogen concentrates and proposals for further therapeutic strategies with plasminogen concentrates.Haemostasis. 1988;18 Suppl 1:165-75. doi: 10.1159/000215851. Haemostasis. 1988. PMID: 3280422 Review.
Cited by
-
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.Blood. 2019 Mar 7;133(10):1152-1163. doi: 10.1182/blood-2018-06-860270. Epub 2018 Dec 27. Blood. 2019. PMID: 30591525 Free PMC article.
-
Model for surface-dependent factor XII activation: the roles of factor XII heavy chain domains.Blood Adv. 2022 May 24;6(10):3142-3154. doi: 10.1182/bloodadvances.2021005976. Blood Adv. 2022. PMID: 35086137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous